China Pharmaceutical Group Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2012. For the year, the company's revenue was HKD 1,555,055,000 compared with HKD 2,176,324,000 a year ago. Operating loss was HKD 54,647,000 compared with profit of HKD 220,756,000 a year ago. Loss before tax was HKD 77,156,000 compared with profit of HKD 209,584,000 a year ago. Loss for the year was HKD 83,360,000 compared with profit of HKD 169,225,000 a year ago. Loss for the year attributable to owners of the company was HKD 85,032,000 or 5.56 cents per basic share compared with HKD 161,541,000 or 10.53 cents per basic share a year ago. For the six months ending June 30, 2012, the company expected a loss.